CLINICAL_TRIALS
trial_result
· 2014-07-21
Clinical Trial Update: Ph I SU011248 + Irinotecan in Treatment of Pts w MG [Phase 1]
Summary
A Phase I trial evaluating SU011248 in combination with irinotecan for glioblastoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Duke University | Conditions: Glioblastoma | Phase 1 | Status: COMPLETED